HealthEquity, Inc. (NASDAQ:HQY) VP Darcy G. Mott sold 9,500 shares of the business’s stock in a transaction that occurred on Monday, November 20th. The stock was sold at an average price of $49.68, for a total transaction of $471,960.00. Following the completion of the sale, the vice president now directly owns 93,500 shares of the company’s stock, valued at $4,645,080. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

HealthEquity, Inc. (NASDAQ:HQY) traded up $1.30 during trading on Wednesday, reaching $51.31. 321,100 shares of the company traded hands, compared to its average volume of 530,656. HealthEquity, Inc. has a twelve month low of $37.62 and a twelve month high of $55.31. The company has a market cap of $3,025.04, a price-to-earnings ratio of 79.38, a price-to-earnings-growth ratio of 2.19 and a beta of 1.77.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, September 5th. The company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.14 by $0.13. The firm had revenue of $56.90 million for the quarter, compared to the consensus estimate of $55.66 million. HealthEquity had a net margin of 20.27% and a return on equity of 13.93%. The business’s quarterly revenue was up 28.7% on a year-over-year basis. During the same period last year, the company posted $0.16 EPS. analysts predict that HealthEquity, Inc. will post 0.7 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “HealthEquity, Inc. (HQY) VP Darcy G. Mott Sells 9,500 Shares” was originally reported by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another publication, it was stolen and reposted in violation of United States & international copyright laws. The original version of this news story can be accessed at https://www.watchlistnews.com/healthequity-inc-hqy-vp-darcy-g-mott-sells-9500-shares/1720103.html.

A number of brokerages have weighed in on HQY. Zacks Investment Research downgraded shares of HealthEquity from a “buy” rating to a “hold” rating in a report on Wednesday, November 15th. BidaskClub upgraded shares of HealthEquity from a “sell” rating to a “hold” rating in a research note on Thursday, September 28th. TheStreet upgraded shares of HealthEquity from a “c” rating to a “b” rating in a research note on Monday, July 31st. Robert W. Baird restated a “hold” rating on shares of HealthEquity in a research note on Thursday, September 21st. Finally, Oppenheimer Holdings, Inc. restated a “buy” rating and issued a $61.00 price objective on shares of HealthEquity in a research note on Wednesday, September 6th. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $57.50.

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. boosted its position in HealthEquity by 3.0% during the second quarter. Vanguard Group Inc. now owns 4,237,298 shares of the company’s stock worth $211,145,000 after purchasing an additional 122,061 shares during the period. First Trust Advisors LP boosted its position in HealthEquity by 17.0% during the second quarter. First Trust Advisors LP now owns 94,283 shares of the company’s stock worth $4,698,000 after purchasing an additional 13,676 shares during the period. Dimensional Fund Advisors LP boosted its position in HealthEquity by 25.3% during the second quarter. Dimensional Fund Advisors LP now owns 473,433 shares of the company’s stock worth $23,591,000 after purchasing an additional 95,514 shares during the period. Fred Alger Management Inc. boosted its position in shares of HealthEquity by 30.4% in the second quarter. Fred Alger Management Inc. now owns 265,369 shares of the company’s stock valued at $13,223,000 after acquiring an additional 61,880 shares during the period. Finally, Russell Investments Group Ltd. bought a new stake in shares of HealthEquity in the second quarter valued at about $1,362,000. Institutional investors and hedge funds own 93.19% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Insider Buying and Selling by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.